Boxer Capital Management, LLC Q3 2025 Filing

Filed November 14, 2025

Portfolio Value

$313.7B

Holdings

34

Report Date

Q3 2025

Filing Type

13F-HR

All Holdings (34 positions)

#StockSharesValue% PortfolioType
1
TNGXTANGO THERAPEUTICS INC
9,771,485$82.1B26.16%
2
QUREUNIQURE NV
800,000$46.7B14.88%
3
RVMDREVOLUTION MEDICINES INC
400,000$18.7B5.95%
4
KYMRKYMERA THERAPEUTICS INC
319,100$18.1B5.76%
5
KODKODIAK SCIENCES INC
750,000$12.3B3.91%
6
PTCTPTC THERAPEUTICS INC
200,000$12.3B3.91%
7
AMLXAMYLYX PHARMACEUTICALS INC
900,000$12.2B3.90%
8
URGNUROGEN PHARMA LTD
575,000$11.5B3.66%
9
MRUSMERUS N V
120,000$11.3B3.60%
10
CYTKCYTOKINETICS INC
200,000$11.0B3.50%
11
ABVXABIVAX SA
120,000$10.2B3.25%
12
PTGXPROTAGONIST THERAPEUTICS INC
110,000$7.3B2.33%
13
NKTRNEKTAR THERAPEUTICS
125,000$7.1B2.27%
14
CBIOCRESCENT BIOPHARMA INC.
453,686$5.4B1.72%
15
INOINOVIO PHARMACEUTICALS INC
2,300,000$5.4B1.72%
16
SRPTSAREPTA THERAPEUTICS INC
250,000$4.8B1.54%
17
CDTXCIDARA THERAPEUTICS INC
48,000$4.6B1.47%
18
CELCCELCUITY INC
90,000$4.4B1.42%
19
REPLREPLIMUNE GROUP INC
1,050,000$4.4B1.40%
20
SLDBSOLID BIOSCIENCES INC
600,000$3.7B1.18%
21
DNLIDENALI THERAPEUTICS INC
250,000$3.6B1.16%
22
PGENPRECIGEN INC
850,000$2.8B0.89%
23
APGEAPOGEE THERAPEUTICS INC
50,000$2.0B0.63%
24
BRD1EURMIND MEDICINE MINDMED INC
163,500$1.9B0.61%
25
MLTXMOONLAKE IMMUNOTHERAPEUTICS
250,000$1.8B0.57%
26
NRIXNURIX THERAPEUTICS INC
175,000$1.6B0.52%
27
AVTXAVALO THERAPEUTICS INC
125,000$1.6B0.51%
28
MISTMILESTONE PHARMACEUTICALS IN
666,666$1.3B0.42%
29
PEPGPEPGEN INC
250,000$1.2B0.37%
30
LBRXLB PHARMACEUTICALS INC
70,000$1.1B0.35%
31
TILINSTIL BIO INC
60,700$1.1B0.35%
32
KALVKALVISTA PHARMACEUTICALS INC
20,400$248.5M0.08%
33
NUVB/WSNUVATION BIO INC
266,666$53.9M0.02%
34
SRZNWSURROZEN INC
66,666$1.0M0.00%